Alan O’connell
Director
Cardiology
Veryan
United States of America
Biography
Alan is a Partner at Seroba Life Sciences. Prior to joining Seroba Life Sciences, Alan worked in a variety of product development and business development roles at Elan Corporation (Dublin), American Biogenetic Sciences, Inc. (New York), and the Medicines Control Agency (London). His previous venture capital experience was gained at Estée Lauder Investments (New York) and he still sits on the Lauder Scientific Advisory Board. In addition to Veryan, Alan sits on the boards of Ario Pharma, Opsona, Crescent Diagnostics and Heart Metabolics.
Research Interest
Immunology, Cardiology, Acute Arthritis, Accupuncture